Physician profile
Raphael E Rosenbaum
NPI 1801043211
$11,942.22
in general payments reported to CMS, 2019-2025
15 companies · $2,267 in 2025
The $2,267 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,488 · 2020: $5,132 · 2021: $559 · 2022: $438 · 2023: $575 · 2024: $484 · 2025: $2,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,550 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,550.00 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $7,932.53 | 2020-2025 | Acthar |
| Abbvie INC. | $2,269.25 | 2019 | |
| Oyster Point Pharma, INC. | $500.39 | 2022-2025 | Tyrvaya, Ryzumvi |
| Eyepoint US, INC. | $357.82 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $204.20 | 2020-2023 | |
| Mallinckrodt Enterprises LLC | $166.58 | 2019 | |
| Alcon Vision LLC | $119.93 | 2023-2025 | Rocklatan, Hydrus Microstent |
| Salvin Dental Specialties, INC. | $102.20 | 2021 | |
| Ani Pharmaceuticals, INC. | $93.84 | 2022-2025 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $54.27 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.19 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $34.62 | 2019-2023 | Tecnis Iol, Tecnis Iol, Catalys System |
| Bausch & Lomb Americas INC. | $31.48 | 2025 | Xiidra |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $15.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.